Literature DB >> 27097943

MiR-335 functions as a tumor suppressor and regulates survivin expression in osteosarcoma.

Z-F Liu1, Z-Q Liang, L Li, Y-B Zhou, Z-B Wang, W-F Gu, L-Y Tu, J Zhao.   

Abstract

OBJECTIVE: Previous studies have shown that miR-335 plays an anti-tumor role in several types of cancer. However, whether it is able to regulate the tumorigenesis of osteosarcoma (OS) has not been fully investigated. The present study was designed to study its potential role in regulating apoptosis of OS cells.
MATERIALS AND METHODS: The expression of miR-335 in a total of 18 paired OS tumor tissues and adjacent non-cancerous tissues was measured by Real-time PCR, and its different expression in OS cell lines was also measured. The effect of miR-335 on apoptosis was measured by MTT assay, caspase-3 activity assay and TUNEL assay. The effect of survivin inhibition on apoptosis of OS cells was determined by MTT assay and western blot. Luciferase reporter assay and western blot were conducted to confirm the relationship between miR-335 and the 3'UTR of survivin mRNA.
RESULTS: MiR-335 expression was found to be significantly downregulated in OS tumor tissues and OS cell lines. Overexpression of miR-335 led to decreased cell viability and increased apoptosis. MiR-335 directly targeted the 3'UTR of survivin mRNA and suppressed survivin gene expression, and inhibition of survivin exhibited similar effects to miR-335 overexpression.
CONCLUSIONS: MiR-335 might function as a tumor suppressor in OS, and downregulation of miR-335 in OS cells contributes to the decreased apoptotic potential of OS cells through derepression of survivin.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27097943

Source DB:  PubMed          Journal:  Eur Rev Med Pharmacol Sci        ISSN: 1128-3602            Impact factor:   3.507


  11 in total

Review 1.  miRNA signatures in childhood sarcomas and their clinical implications.

Authors:  G M Viera; K B Salomao; G R de Sousa; M Baroni; L E A Delsin; J A Pezuk; M S Brassesco
Journal:  Clin Transl Oncol       Date:  2019-04-04       Impact factor: 3.405

2.  The Potential Contribution of microRNAs in Anti-cancer Effects of Aurora Kinase Inhibitor (AZD1152-HQPA).

Authors:  Ali Zekri; Yashar Mesbahi; Elham Boustanipour; Zahra Sadr; Seyed H Ghaffari
Journal:  J Mol Neurosci       Date:  2018-07-26       Impact factor: 3.444

3.  MiR-485-5p Suppress the Malignant Characteristics of the Lung Adenocarcinoma via Targeting NADPH Quinone Oxidoreductase-1 to Inhibit the PI3K/Akt.

Authors:  Yupeng Chen; Lin Wu; Min Bao
Journal:  Mol Biotechnol       Date:  2022-10-11       Impact factor: 2.860

4.  miR-335 negatively regulates osteosarcoma stem cell-like properties by targeting POU5F1.

Authors:  Xiaodong Guo; Ling Yu; Zhengpei Zhang; Guo Dai; Tian Gao; Weichun Guo
Journal:  Cancer Cell Int       Date:  2017-02-17       Impact factor: 5.722

5.  Identification of H2O2 induced oxidative stress associated microRNAs in HLE-B3 cells and their clinical relevance to the progression of age-related nuclear cataract.

Authors:  Song Wang; Chenjun Guo; Mengsi Yu; Xiaona Ning; Bo Yan; Jing Zhao; Angang Yang; Hong Yan
Journal:  BMC Ophthalmol       Date:  2018-04-13       Impact factor: 2.209

6.  On the discovery of a potential survivin inhibitor combining computational tools and cytotoxicity studies.

Authors:  Patricia A Quispe; Martin J Lavecchia; Ignacio E León
Journal:  Heliyon       Date:  2019-08-10

7.  circATP2A2 promotes osteosarcoma progression by upregulating MYH9.

Authors:  Xin Cao; Xianfeng Meng; Peng Fu; Lin Wu; Zhen Yang; Huijin Chen
Journal:  Open Med (Wars)       Date:  2021-11-22

8.  miRNA-335 and miRNA-182 affect the occurrence of tongue squamous cell carcinoma by targeting survivin.

Authors:  Deming Ou; Ying Wu; Jun Liu; Xiaomei Lao; Sien Zhang; Guiqing Liao
Journal:  Oncol Lett       Date:  2016-08-03       Impact factor: 2.967

9.  microRNA-544 promoted human osteosarcoma cell proliferation by downregulating AXIN2 expression.

Authors:  Ming Chen; Yong-Yi Liu; Min-Qing Zheng; Xin-Liang Wang; Xing-Hua Gao; Lin Chen; Guang-Ming Zhang
Journal:  Oncol Lett       Date:  2018-03-08       Impact factor: 2.967

10.  A novel oncogenic role for urokinase receptor in leukemia cells: molecular sponge for oncosuppressor microRNAs.

Authors:  Anna Li Santi; Anna Gorrasi; Mariaevelina Alfieri; Nunzia Montuori; Pia Ragno
Journal:  Oncotarget       Date:  2018-06-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.